Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in […]
Patent delisted for Veloxis Pharms drug ENVARSUS XR Read Post »
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one
Patent delisted for Otsuka drug ABILIFY MYCITE KIT Read Post »
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA.
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Read Post »
DEXYCU KIT (dexamethasone) Eyepoint pharms Patent: 10,022,502 Expiration: Sep 12, 2020 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of September 6, 2020 Read Post »
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug GLYXAMBI Read Post »
Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one
Patent delisted for Purdue Pharma drug OXYCONTIN Read Post »
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug TRADJENTA Read Post »
Get fresh news and insights, drug patent expirations & more…
